Loading data
PDEXNasdaq
| Unit: USD | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 77.55 m USD | 66.59 m USD | 53.84 m USD | 46.09 m USD | 42.04 m USD |
| Cost of revenue | 53.21 m USD | 47.08 m USD | 39.29 m USD | 33.34 m USD | 28.91 m USD |
| Gross profit | 24.34 m USD | 19.51 m USD | 14.55 m USD | 12.75 m USD | 13.13 m USD |
| Research and development expense | 3.35 m USD | 3.64 m USD | 3.19 m USD | 2.8 m USD | 2.98 m USD |
| Selling, general and administrative expense | 8 m USD | 5.19 m USD | — | — | — |
| Operating profit | 12.99 m USD | 10.69 m USD | 7.17 m USD | 5.76 m USD | 5.12 m USD |
| Interest expense | — | — | — | 533 k USD | 464 k USD |
| Profit before tax | 18.02 m USD | 12.06 m USD | 2.63 m USD | 9.43 m USD | 5.69 m USD |
| Income tax expense | 4.35 m USD | 3.08 m USD | 507 k USD | 2.35 m USD | 1.12 m USD |
| Net income (reported basis) | 13.66 m USD | 8.98 m USD | 2.13 m USD | 7.07 m USD | 4.57 m USD |
| Basic earnings per share | 4.24 USD/share | 2.73 USD/share | 0.61 USD/share | 1.98 USD/share | 1.26 USD/share |
| Diluted earnings per share | 4.12 USD/share | 2.67 USD/share | 0.6 USD/share | 1.95 USD/share | 1.21 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.